Gene · 4855
Papers3,624
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 3,624
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification of acquired Notch3 dependency in metastatic Head and Neck Cancer. | Commun Biol | 2023 | 37202533 | PubTator, text mining | PubMed |
| Molecular and phenotypic characteristics influencing the degree of cytoreduction in high-grade serous ovarian carcinomas. | Cancer Med | 2023 | 37191035 | PubTator, text mining | PubMed |
| Reviewing the Prospective Pharmacological Potential of Isothiocyanates in Fight against Female-Specific Cancers. | Cancers (Basel) | 2023 | 37190316 | PubTator, text mining | PubMed |
| Current Progress on Predictive Biomarkers for Response to Immune Checkpoint Inhibitors in Gastric Cancer: How to Maximize the Immunotherapeutic Benefit? | Cancers (Basel) | 2023 | 37190201 | PubTator, text mining | PubMed |
| Gene Fusion Detection in NSCLC Routine Clinical Practice: Targeted-NGS or FISH? | Cells | 2023 | 37190044 | PubTator, text mining | PubMed |
| Upregulated expression of Notch1/4 - JAG-1/DLL-1 detected in allergic rhinitis. | Allergy Asthma Clin Immunol | 2023 | 37183251 | PubTator, text mining | PubMed |
| Construction and validation of a prognostic model for predicting clear cell renal cell carcinoma based on complement-related genes. | Transl Androl Urol | 2023 | 37181236 | PubTator, text mining | PubMed |
| Self-Renewal and Pluripotency in Osteosarcoma Stem Cells' Chemoresistance: Notch, Hedgehog, and Wnt/β-Catenin Interplay with Embryonic Markers. | Int J Mol Sci | 2023 | 37176108 | PubTator, text mining | PubMed |
| MYCN Amplification Is Associated with Reduced Expression of Genes Encoding γ-Secretase Complex and NOTCH Signaling Components in Neuroblastoma. | Int J Mol Sci | 2023 | 37175848 | PubTator, text mining | PubMed |
| Targeted Genomic Profiling and Chemotherapy Outcomes in Grade 3 Gastro-Entero-Pancreatic Neuroendocrine Tumors (G3 GEP-NET). | Diagnostics (Basel) | 2023 | 37174986 | PubTator, text mining | PubMed |
| Demographics and Clinicopathologic Profile of Pulmonary Sarcomatoid Carcinoma with Survival Analysis and Genomic Landscape. | Cancers (Basel) | 2023 | 37173936 | PubTator, text mining | PubMed |
| Pancreatic cancer stemness: dynamic status in malignant progression. | J Exp Clin Cancer Res | 2023 | 37173787 | PubTator, text mining | PubMed |
| Ambient air pollution and infant health: a narrative review. | EBioMedicine | 2023 | 37169689 | PubTator, text mining | PubMed |
| Self-organized yolk sac-like organoids allow for scalable generation of multipotent hematopoietic progenitor cells from induced pluripotent stem cells. | Cell Rep Methods | 2023 | 37159663 | PubTator, text mining | PubMed |
| Genomic landscape of pancreatic cancer in the Japanese version of the Cancer Genome Atlas. | Ann Gastroenterol Surg | 2023 | 37152777 | PubTator, text mining | PubMed |
| Silencing Notch4 promotes tumorigenesis and inhibits metastasis of triple-negative breast cancer via Nanog and Cdc42. | Cell Death Discov | 2023 | 37149651 | PubTator, text mining | PubMed |
| Long non-coding RNAs regulate treatment outcome in leukemia: What have we learnt recently? | Cancer Med | 2023 | 37148556 | PubTator, text mining | PubMed |
| Inferring ligand-receptor cellular networks from bulk and spatial transcriptomic datasets with BulkSignalR. | Nucleic Acids Res | 2023 | 37144485 | PubTator, text mining | PubMed |
| Multiomics endotyping of preterm infants with bronchopulmonary dysplasia and pulmonary hypertension-A pilot study. | Pulm Circ | 2023 | 37123538 | PubTator, text mining | PubMed |
| Targeting Non-Coding RNAs for the Development of Novel Hepatocellular Carcinoma Therapeutic Approaches. | Pharmaceutics | 2023 | 37111734 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4855/papers?page=19